 SEATTLE, Dec. 29, 2021 GLOBE NEWSWIRE -- Adaptive Biotechnologies Corporation Adaptive Biotechnologies Nasdaq: ADPT, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference. 